Oral pulsatile delivery systems based on swellable hydrophilic polymers

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 68, Issue 1, 2008, Pages 11-18

  Gazzaniga, Andrea ^a   Palugan, Luca ^a   Foppoli, Anastasia ^a   Sangalli, Maria Edvige ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Dissolution; Erosion; Hydrophilic cellulose derivatives; Oral pulsatile delayed release; Swellable hydrophilic polymers; Swelling

Indexed keywords

CELLULOSE; POLYMER;

BIOCOMPATIBILITY; CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; HYDROGEL; ORAL DRUG ADMINISTRATION; REVIEW;

ADMINISTRATION, ORAL; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; HYDROPHOBICITY; PHARMACEUTICAL PREPARATIONS; POLYMERS; SOLUBILITY;

EID: 36549071061     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2007.05.022     Document Type: Review

References (65)

1. Colombo P. Swelling-controlled release in hydrogel matrices for oral route. Adv. Drug Deliv. Rev. 11 (1993) 37-57
2. Caramella C., Ferrari F., Bonferoni M.C., and Ronchi M. Rheological properties and diffusion dissolution behaviour of hydrophilic polymers. Boll. Chim. Farm. 128 (1989) 298-302
3. Colombo P., Gazzaniga A., Caramella C., Conte U., and La Manna A. In vitro programmable zero-order release drug delivery system. Acta Pharm. Technol. 33 (1987) 15-20
4. Conte U., Colombo P., Gazzaniga A., Sangalli M.E., and La Manna A. Swelling-activated drug delivery systems. Biomaterials 9 (1988) 489-493
5. Colombo P., Bettini R., Santi P., and Peppas N.A. Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance. Pharm. Sci. Technol. Today 3 (2000) 198-204
6. Peppas N.A., Bures P., Leobandung W., and Ichikawa H. Hydrogels in pharmaceutical formulations. Eur. J. Pharm. Biopharm. 50 (2000) 27-46
7. Li C.L., Martini L.G., Ford J.L., and Roberts M. The use of hypromellose in oral drug delivery. J. Pharm. Pharmacol. 57 (2005) 533-546
8. Maroni A., Zema L., Cerea M., and Sangalli M.E. Oral pulsatile drug delivery systems. Expert Opin. Drug Deliv. 2 (2005) 855-871
9. Lemmer B. Circadian rhythms and drug delivery. J. Control. Release 16 (1991) 63-74
10. Hrushesky W.J.M. Timing is everything. Sciences 34 (1994) 32-37
11. Smolensky M.H., Reinberg A.E., Martin R.J., and Haus E. Clinical chronobiology and chronotherapeutics with application to asthma. Chronobiol. Int. 16 (1999) 539-563
12. Youan B.B.C. Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery?. J. Control. Release 98 (2004) 337-353
13. Gazzaniga A., Giordano F., Sangalli M.E., and Zema L. Oral colon-specific drug delivery: design strategies. STP Pharma Prat. 4 (1994) 336-343
14. Gazzaniga A., Maroni A., Sangalli M.E., and Zema L. Time-controlled oral delivery systems for colon targeting. Expert Opin. Drug Deliv. 3 (2006) 583-597
15. Friend D.R. New oral delivery systems for treatment of inflammatory bowel disease. Adv. Drug Deliv. Rev. 57 (2005) 247-265
16. Rubinstein A., Tirosh B., Baluom M., Nassar T., David A., Radai R., Gliko-Kabir I., and Friedman M. The rationale for peptide drug delivery to the colon and the potential of polymeric carriers as effective tools. J. Control. Release 46 (1997) 59-73
17. Bourgeois S., Harvey R., and Fattal E. Polymer colon drug delivery systems and their application to peptides, proteins, and nucleic acids. Am. J. Drug Deliv. 3 (2005) 171-204
18. Davis S.S. The design and evaluation of controlled release systems for the gastro-intestinal tract. J. Control. Release 2 (1985) 27-38
19. Bussemer T., Otto I., and Bodmeier R. Pulsatile drug-delivery systems. Crit. Rev. Ther. Drug Carrier Syst. 18 (2001) 433-458
20. Conte U., Colombo P., La Manna A., Gazzaniga A., Sangalli M.E., and Giunchedi P. A new ibuprofen pulsed release oral dosage form. Drug Dev. Ind. Pharm. 15 (1989) 2583-2596
21. Conte U., Giunchedi P., Maggi L., Sangalli M.E., Gazzaniga A., Colombo P., and La Manna A. Ibuprofen delayed release dosage forms: a proposal for the preparation of an in vitro/in vivo pulsatile system. Eur. J. Pharm. Biopharm. 38 (1992) 209-212
22. Maffione G., Iamartino P., Guglielmini G., and Gazzaniga A. High-viscosity HPMC as a film-coating agent. Drug Dev. Ind. Pharm. 19 (1993) 2043-2053
23. Gazzaniga A., Iamartino P., Maffione G., and Sangalli M.E. Oral delayed-release system for colonic specific delivery. Int. J. Pharm. 108 (1994) 77-83
24. ® drug delivery systems: achievement of time and/or site specificity. Eur. J. Pharm. Biopharm. 40 (1994) 246-250
25. Gazzaniga A., Busetti C., Moro L., Sangalli M.E., and Giordano F. Time-dependent oral delivery systems for colon targeting. STP Pharma Sci. 5 (1995) 83-88
26. Sangalli M.E., Maroni A., Zema L., Busetti C., Giordano F., and Gazzaniga A. In vitro and in vivo evaluation of an oral system for time and/or site-specific drug delivery. J. Control. Release 73 (2001) 103-110
27. Sangalli M.E., Maroni A., Foppoli A., Zema L., Giordano F., and Gazzaniga A. Different HPMC viscosity grades as coating agents for an oral time and/or site-controlled delivery system: a study on process parameters and in vitro performances. Eur. J. Pharm. Sci. 22 (2004) 469-476
28. Zema L., Maroni A., Foppoli A., Palugan L., Sangalli M.E., and Gazzaniga A. Different HPMC viscosity grades as coating agents for an oral time and/or site-controlled delivery system: an investigation into the mechanisms governing drug release. J. Pharm. Sci. 96 (2007) 1527-1536
29. Maroni A., Sangalli M.E., Cerea M., Busetti C., Giordano F., and Gazzaniga A. Low viscosity HPMC coating of soft- and hard-gelatin capsules for delayed and colonic release: preliminary investigations on process parameters and in vitro release performances. Proceed. Int. Symp. Control. Rel. Bioact. Mater. 26 (1999) 885-886
30. Couvreur P., and Puisieux F. Nano- and microparticles for the delivery of polypeptides and proteins. Adv. Drug Deliv. Rev. 10 (1993) 141-162
31. Jung T., Kamm W., Breitenbach A., Kaiserling E., Xiao J.X., and Kissel T. Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?. Eur. J. Pharm. Biopharm. 50 (2000) 147-160
32. Pirulli V., Cerea M., Maroni A., Zema L., Giordano F., and Gazzaniga A. HPMC-coating of tablets in tangential-spray rotary fluid bed for the achievement of an oral time and/or site-controlled delivery system. Proceed. Int. Symp. Control. Rel. Bioact. Mater. 31 (2004) 391-392
33. Cerea M., Serratoni M., Maroni A., Foppoli A., Palugan L., Sangalli M.E., and Gazzaniga A. Preparation of an oral time-controlled delivery system by HPMC powder-layering. Proceed. Int. Symp. Control. Rel. Bioact. Mater. 33 (2006) 882
34. Conte U., Maggi L., Giunchedi P., and La Manna A. New oral system for timing-release of drugs. Boll. Chim. Farm. 131 (1992) 199-204
35. Conte U., Maggi L., Torre M.L., Giunchedi P., and La Manna A. Press-coated tablets for time-programmed release of drugs. Biomaterials 14 (1993) 1017-1023
36. Halsas M., Ervasti P., Veski P., Jürjenson H., and Marvola M. Biopharmaceutical evaluation of time-controlled press-coated tablets containing polymers to adjust drug release. Eur. J. Drug Metab. Pharmacokinet. 23 (1998) 190-196
37. Halsas M., Simelius R., Kiviniemi A., Veski P., Jürjenson H., and Marvola M. Effect of different combinations of hydroxypropylmethyl cellulose on bioavailability of ibuprofen from press-coated time-controlled tablets. STP Pharma Sci. 8 (1998) 155-161
38. Halsas M., Penttinen T., Veski P., Jürjenson H., and Marvola M. Time-controlled release pseudoephedrine tablets: bioavailability and in vitro/in vivo correlations. Pharmazie 56 (2001) 718-723
39. Qi M., Wang P., and Wu D. A novel pH- and time-dependent system for colonic drug delivery. Drug Dev. Ind. Pharm. 29 (2003) 661-667
40. Li Y.H., and Zhu J.B. Modulation of combined-release behaviors from a novel tablets-in-capsule system. J. Control. Release 95 (2004) 381-389
41. Matsuo M., Nakamura C., Arimori K., and Nakano M. Evaluation of hydroxyethylcellulose as a hydrophilic swellable material for delayed-release tablets. Chem. Pharm. Bull. 43 (1995) 311-314
42. Matsuo M., Arimori K., Nakamura C., and Nakano M. Delayed-release tablets using hydroxyethylcellulose as a gel-forming matrix. Int. J. Pharm. 138 (1996) 225-235
43. Fukui E., Uemura K., and Kobayashi M. Studies on applicability of press-coated tablets using hydroxypropylcellulose (HPC) in the outer shell for timed-release preparations. J. Control. Release 68 (2000) 215-223
44. Fukui E., Miyamura N., Uemura K., and Kobayashi M. Preparation of enteric coated timed-release press-coated tablets and evaluation of their function by in vitro and in vivo tests for colon targeting. Int. J. Pharm. 204 (2000) 7-15
45. Vandelli M.A., Leo E., Forni F., and Bernabei M.T. In vitro evaluation of a potential colonic delivery system that releases drug after a controllable lag-time. Eur. J. Pharm. Biopharm. 42 (1996) 148-151
46. Takeuchi H., Yasuji T., Yamamoto H., and Kawashima Y. Spray-dried lactose composite particles containing an ion complex of alginate-chitosan for designing a dry-coated tablet having a time-controlled releasing function. Pharm. Res. 17 (2000) 94-99
47. Sawada T., Sako K., Fukui M., Yokohama S., and Hayashi M. A new index, the core erosion ratio, of compression-coated timed-release tablets predicts the bioavailability of acetaminophen. Int. J. Pharm. 265 (2003) 55-63
48. http://www.penwest.com/syncrodose.html (2006).
49. Hariharan M., and Gupta V.K. ENCORE: a novel compression-coated tablet dosage form. Proceed. Int. Symp. Control. Rel. Bioact. Mater. 28 (2001) 6102
50. Ozeki Y., Ando M., Watanabe Y., and Danjo K. Evaluation of novel one-step dry-coated tablets as a platform for delayed-release tablets. J. Control. Release 95 (2004) 51-60
51. Cao Q.R., Choi H.G., Kim D.C., and Lee B.J. Release behavior and photo-image of nifedipine tablet coated with high viscosity grade hydroxypropylmethylcellulose: effect of coating conditions. Int. J. Pharm. 274 (2004) 107-117
52. Wilding I.R., Davis S.S., Bakhshaee M., Stevens H.N.E., Sparrow R.A., and Brennan J. Gastrointestinal transit and systemic absorption of captopril from a pulsed-release formulation. Pharm. Res. 9 (1992) 654-657
53. Binns J., Stevens H.N.E., McEwen J., Pritchard G., Brewer F.M., Clarke A., Johnson E.S., and McMillan I. The tolerability of multiple oral doses of Pulsincap™ capsules in healthy volunteers. J. Control. Release 38 (1996) 151-158
54. Wilson C.G., Bakhshaee M., Stevens H.N.E., Perkins A.C., Frier M., Blackshaw E.P., and Binns J.S. Evaluation of a gastro-resistant pulsed release delivery system (Pulsincap) in humans. Drug Deliv. 4 (1997) 201-206
55. Hebden J.M., Wilson C.G., Spiller R.C., Gilchrist P.J., Blackshaw E., Frier M.E., and Perkins A.C. Regional differences in quinine absorption from the undisturbed human colon assessed using a timed release delivery system. Pharm. Res. 16 (1999) 1087-1092
56. Hebden J.M., Gilchrist P.J., Perkins A.C., Wilson C.G., and Spiller R.C. Stool water content and colonic drug absorption: contrasting effects of lactulose and codeine. Pharm. Res. 16 (1999) 1254-1259
57. Stevens H.N.E., Wilson C.G., Welling P.G., Bakhshaee M., Binns J.S., Perkins A.C., Frier M., Blackshaw E.P., Frame M.W., Nichols D.J., Humphrey M.J., and Wicks S.R. Evaluation of Pulsincap™ to provide regional delivery of dofetilide to the human GI tract. Int. J. Pharm. 236 (2002) 27-34
58. Krögel I., and Bodmeier R. Pulsatile drug release from an insoluble capsule body controlled by an erodible plug. Pharm. Res. 15 (1998) 474-481
59. Ross A.C., MacRae R.J., Walther M., and Stevens H.N.E. Chronopharmaceutical drug delivery from a pulsatile capsule device based on programmable erosion. J. Pharm. Pharmacol. 52 (2000) 903-909
60. Gohel M.C., and Sumitra G.M. Modulation of active pharmaceutical material release from a novel tablet in capsule system containing an effervescent blend. J. Control. Release 79 (2002) 157-164
61. McConville J.T., Ross A.C., Chambers A.R., Smith G., Florence A.J., and Stevens H.N.E. The effect of wet granulation on the erosion behaviour of an HPMC-lactose tablet, used as a rate-controlling component in a pulsatile drug delivery capsule formulation. Eur. J. Pharm. Biopharm. 57 (2004) 541-549
62. Sutch J.C.D., Ross A.C., Köckenberger W., Bowtell R.W., MacRae R.J., Stevens H.N.E., and Melia C.D. Investigating the coating-dependent release mechanism of a pulsatile capsule using NMR microscopy. J. Control. Release 92 (2003) 341-347
63. McConville J.T., Ross A.C., Florence A.J., and Stevens H.N.E. Erosion characteristics of an erodible tablet incorporated in a time-delayed capsule device. Drug Dev. Ind. Pharm. 31 (2005) 79-89
64. Lee W.W., O'Mahony B., Bar-Shalom D., Slot L., Wilson C.G., Blackshaw P.E., and Perkins A.C. Scintigraphic characterisation of a novel injection-moulded dosage form. Proceed. Int. Symp. Control. Rel. Bioact. Mater. 27 (2000) 1288-1289
65. ®) for pulsatile peptide delivery in man. Proceed. Int. Symp. Control. Rel. Bioact. Mater. 28 (2001) 983-984